用 Codex 或 Claude 帮你安装 复制这段 Prompt,粘贴到 Codex、Claude 或其他助手里,让它检查 Skill 页面并帮你完成安装。
直接命令不会经过审查 Prompt;运行前请先检查来源。
npx skills add https://github.com/brycewang-stanford/Auto-Empirical-Research-Skills --skill llm-scientific-discovery-guide命令会保持在同一行。复制前请横向滚动并检查完整内容。
想先保存到本地?可下载 SkillsMP 当前能够提供的文件。
Route empirical-research requests through the Auto-Empirical Research Skills catalog when this whole repository is installed as one skill in Codex, CodeBuddy, Claude Code, or another IDE. Use to choose and load the right vendored AERS skill for causal inference, econometrics, replication, data acquisition, manuscript writing, peer review and referee responses, citation checking, de-AIGC editing, or full empirical-paper workflows without reading the entire repository at once.
中英双语学术降 AIGC / bilingual academic de-AIGC skill. Removes AI-generated writing signatures from empirical papers in economics, management, and the social sciences — in both English and Chinese. Covers Turnitin AI, GPTZero, Originality.ai on the English side and 知网 AMLC, 万方, 维普 on the Chinese side. Uses a six-step loop (intake → audit → claim-evidence check → differentiated rewrite → five-dimension self-score → cold-reader recheck) with two pattern libraries (22 English + 17 Chinese patterns), section-by-section strategies for empirical papers, and hard protections that keep every number, coefficient, and citation intact.
Use when a research task needs reproducible Kaggle discovery, metadata inspection, bounded public-data downloads, competition or kernel discovery, model discovery, or an explicitly approved Kaggle write/delete operation through the official CLI.
基于 SOC 职业分类
正在显示 SKILL.md
| name | llm-scientific-discovery-guide |
| description | Survey of LLM agents for biomedical scientific discovery |
| metadata | {"openclaw":{"emoji":"🧬","category":"research","subcategory":"deep-research","keywords":["LLM agents","scientific discovery","biomedical AI","drug discovery","hypothesis generation","lab automation"],"source":"https://github.com/zjlrock777/Awesome-LLM-Agents-Scientific-Discovery"}} |
A curated survey of how LLM-based agents are being applied to scientific discovery, with a focus on biomedical research. Covers hypothesis generation, experiment design, lab automation, literature synthesis, and multi-agent scientific collaboration. Tracks papers, tools, and frameworks across the spectrum from fully autonomous to human-in-the-loop systems.
LLM Agents for Scientific Discovery
├── Hypothesis Generation
│ ├── Literature-based (gap identification)
│ ├── Data-driven (pattern discovery)
│ └── Analogy-based (cross-domain transfer)
├── Experiment Design
│ ├── Protocol generation
│ ├── Parameter optimization
│ └── Control selection
├── Lab Automation
│ ├── Robot control (self-driving labs)
│ ├── Equipment programming
│ └── Data collection orchestration
├── Analysis & Interpretation
│ ├── Statistical analysis
│ ├── Visualization
│ └── Result interpretation
└── Communication
├── Paper writing
├── Presentation generation
└── Peer review simulation
| System | Domain | Capability |
|---|---|---|
| AI Scientist | ML/AI | Full paper generation pipeline |
| ChemCrow | Chemistry | Tool-augmented chemical reasoning |
| Coscientist | Chemistry | Autonomous experiment execution |
| BioPlanner | Biology | Experiment protocol generation |
| MedAgent | Medicine | Clinical trial analysis |
| GenAgent | Genomics | Gene expression analysis |
| DrugAgent | Pharma | Drug interaction prediction |
# LLM-based hypothesis generation pattern
from scientific_agent import HypothesisGenerator
generator = HypothesisGenerator(
llm_provider="anthropic",
knowledge_sources=["pubmed", "openalex"],
)
hypotheses = generator.generate(
domain="oncology",
context="Recent findings show that gut microbiome "
"composition correlates with immunotherapy response",
constraints=[
"Must be testable in vitro",
"Should involve specific bacterial species",
"Must have measurable endpoints",
],
num_hypotheses=5,
)
for h in hypotheses:
print(f"\nHypothesis: {h.statement}")
print(f" Rationale: {h.rationale}")
print(f" Supporting evidence: {len(h.evidence)} papers")
print(f" Novelty score: {h.novelty_score:.2f}")
print(f" Feasibility: {h.feasibility}")
# Agent controlling automated experiments
from scientific_agent import LabAgent
agent = LabAgent(
llm_provider="anthropic",
equipment=["plate_reader", "liquid_handler", "incubator"],
safety_constraints=["bsl2", "max_volume_1ml"],
)
# Design and run experiment
result = agent.run_experiment(
objective="Determine IC50 of compound X against cell line Y",
protocol_type="dose_response",
parameters={
"compound": "Compound_X",
"cell_line": "HeLa",
"concentrations": "serial_dilution",
"replicates": 3,
"readout": "cell_viability",
},
)
print(f"IC50: {result.ic50:.2f} uM")
print(f"R-squared: {result.r_squared:.3f}")
result.plot_dose_response("dose_response.pdf")
# Agents with different scientific roles
from scientific_agent import ScientificTeam
team = ScientificTeam(
agents={
"PI": {"role": "research_director",
"expertise": "oncology"},
"Experimentalist": {"role": "experiment_design",
"expertise": "cell_biology"},
"Analyst": {"role": "data_analysis",
"expertise": "biostatistics"},
"Writer": {"role": "manuscript_writing",
"expertise": "scientific_communication"},
},
)
# Collaborative research cycle
project = team.start_project(
title="Microbiome-immunotherapy interaction study",
timeline_weeks=12,
)
# Agents collaborate: PI directs → Experimentalist designs →
# Analyst processes → Writer documents
### Foundational Papers
1. "The AI Scientist" (Lu et al., 2024) — Fully automated ML research
2. "ChemCrow" (Bran et al., 2023) — Chemistry tool-use agent
3. "Coscientist" (Boiko et al., 2023) — Autonomous chemical research
4. "BioPlanner" (Biswas et al., 2024) — Biology protocol generation
### Surveys
5. "Scientific Discovery in the Age of AI" (Wang et al., 2023)
6. "Foundation Models for Science" (Bommasani et al., 2022)
7. "LLM Agents: A Survey" (multiple, 2024)
### Ethics & Limitations
8. "Dual-use concerns of AI in biology" (Sandbrink, 2023)
9. "Can LLMs Generate Novel Research Ideas?" (Si et al., 2024)